Faithward Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $340K | Buy |
1,316
+16
| +1% | +$4.13K | 0.05% | 207 |
|
|
2025
Q1 | $291K | Buy |
1,300
+21
| +2% | +$4.7K | 0.05% | 213 |
|
|
2024
Q4 | $292K | Buy |
1,279
+53
| +4% | +$12.1K | 0.05% | 207 |
|
|
2024
Q3 | $299K | Buy |
1,226
+11
| +0.9% | +$2.69K | 0.05% | 222 |
|
|
2024
Q2 | $233K | Sell |
1,215
-56
| -4% | -$10.7K | 0.04% | 230 |
|
|
2024
Q1 | $252K | Buy |
+1,271
| New | +$252K | 0.05% | 221 |
|
|
2022
Q3 | – | Sell |
-1,689
| Closed | -$354K | – | 267 |
|
|
2022
Q2 | $354K | Sell |
1,689
-246
| -13% | -$51.6K | 0.08% | 108 |
|
|
2022
Q1 | $470K | Sell |
1,935
-178
| -8% | -$43.2K | 0.09% | 103 |
|
|
2021
Q4 | $550K | Sell |
2,113
-1,500
| -42% | -$390K | 0.1% | 92 |
|
|
2021
Q3 | $952K | Sell |
3,613
-1,160
| -24% | -$306K | 0.18% | 70 |
|
|
2021
Q2 | $1.18M | Sell |
4,773
-12,734
| -73% | -$3.14M | 0.23% | 57 |
|
|
2021
Q1 | $3.4M | Buy |
+17,507
| New | +$3.4M | 0.76% | 35 |
|
|
2020
Q4 | – | Sell |
-22,559
| Closed | -$3.87M | – | 197 |
|
|
2020
Q3 | $3.87M | Sell |
22,559
-4,214
| -16% | -$722K | 0.94% | 37 |
|
|
2020
Q2 | $5.14M | Buy |
26,773
+5,025
| +23% | +$965K | 1.33% | 21 |
|
|
2020
Q1 | $3.2M | Buy |
21,748
+19,762
| +995% | +$2.91M | 0.9% | 25 |
|
|
2019
Q4 | $308K | Buy |
+1,986
| New | +$308K | 0.07% | 129 |
|